The approval is based on data from the Phase III FIDELIO-DKD renal outcomes study More: Bayer’s Kerendia approved in the US to slow CKD in type 2 diabetes patients Source: News
read moreFunding will go towards a number of measures aimed at speeding up cancer diagnosis and treatment More: NHS invests £20m to fast-track measures for quick cancer diagnosis Source: News
read moreUK approval of the acquisition comes just a week after the merger scored clearance in the EU More: AZ scores final clearance for Alexion acquisition in the UK Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals